Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
HEDA Ventures is a venture capital firm founded in 2008, focusing on early-stage investments in the biotech, healthcare, and technology, media, and telecommunications (TMT) sectors. The firm launched its U.S. fund in October 2016 and is headquartered in Sunnyvale, California. HEDA Ventures aims to support entrepreneurs in achieving business expansion and leveraging global market opportunities.
As of now, HEDA Ventures manages approximately $150 million in assets under management (AUM) and has completed 9 investments across 8 portfolio companies. The firm typically engages in 2 to 6 deals per year, with a check size ranging from $10 million to $50 million. HEDA Ventures emphasizes cross-border market expansion, particularly between the U.S. and Asia, to enhance growth potential for its investments.
HEDA Ventures primarily invests in early-stage companies within the biotech, healthcare, and TMT sectors. The firm is particularly interested in businesses that are developing breakthroughs in these industries, with a strong emphasis on digital health, IoT, big data, cloud computing, enterprise software, and smart systems. HEDA Ventures seeks to support companies that demonstrate innovative solutions and have the potential for significant market impact.
The firm operates mainly in North America, specifically the United States, and focuses on seed and Series A funding stages. HEDA Ventures looks for founders who are not only passionate about their projects but also possess a clear vision for market expansion. The organization values cross-border opportunities, leveraging its global network to facilitate access to resources and market entry for its portfolio companies.
HEDA Ventures has invested in a diverse range of companies, focusing on innovative solutions in the biotech and healthcare sectors. Notable portfolio companies include:
These companies exemplify HEDA Ventures' commitment to supporting groundbreaking advancements in healthcare and biotechnology.
Hongbin Zheng: General Partner at HEDA Ventures, brings extensive experience in venture capital and a strong background in technology investments.
Lin Xie: Managing Partner, has a proven track record in supporting early-stage companies and driving growth in the biotech sector.
Qiang Chen: Venture Partner, specializes in healthcare investments and has a background in operational management within the industry.
Jun Li: Venture Partner, focuses on technology investments and has experience in scaling startups in the TMT sectors.
To pitch HEDA Ventures, founders should email info@hedaventures.com with a comprehensive pitch deck. The deck should include details about the business model, market opportunity, competitive landscape, and team background. HEDA Ventures prefers well-structured presentations that clearly outline the startup's vision and growth strategy.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are beneficial but not mandatory.
In recent activity, HEDA Ventures has participated in several notable funding rounds, including the Series B round for Hangzhou Just Biotherapeutics, which was led by Temasek. The firm continues to engage in the biotech sector, focusing on companies that address critical healthcare challenges.
HEDA Ventures has also been active in industry conferences, including the BCIC CEO & Investor Conference 2025 and JPM Week 2025 Partnering, indicating ongoing efforts to source new investment opportunities and expand its portfolio.
What are HEDA Ventures' investment criteria?
HEDA Ventures invests in early-stage companies primarily in the biotech, healthcare, and TMT sectors. They focus on seed and Series A funding stages, looking for innovative solutions that have the potential for significant market impact.
How can I pitch to HEDA Ventures?
Founders can reach out via email at info@hedaventures.com. It is advisable to include a detailed pitch deck outlining the business model, market opportunity, and team background.
What makes HEDA Ventures different from other investors?
HEDA Ventures emphasizes cross-border opportunities, particularly between the U.S. and Asia, providing strategic support and access to a global network for its portfolio companies.
What is the typical check size for investments?
HEDA Ventures typically invests between $10 million and $50 million per deal, depending on the stage and potential of the company.
What is the firm's post-investment involvement like?
HEDA Ventures actively supports its portfolio companies by leveraging its global network to facilitate market expansion and access to resources, enhancing growth potential.
How many investments does HEDA Ventures make each year?
The firm typically engages in 2 to 6 investments per year, focusing on high-potential early-stage companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.